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Abstract
Background: In accordance with the 1st International pediatric sepsis consensus conference,
where sepsis was defined as SIRS associated with suspected or proven infection, we have identified
the need to assess the prevalence of SIRS and sepsis in children with abnormal temperatures
hospitalized in The Children's Clinical University Hospital in Latvia.
Methods: A descriptive prospective point prevalence study (using two time periods, each 24 h,
randomly chosen) was conducted on all children (n = 943) treated in the hospital. All children with
abnormal temperatures – fever or hypothermia (n = 92) – were included in the study.
Questionnaires evaluating age-specific SIRS criteria were completed. The prevalence of SIRS was
detected with 95% CI.
Results: Out of a total of 943 patients treated in the hospital, 10% (n = 92) had abnormal
temperatures. In all these cases the abnormal temperature was a fever; hypothermia was not
established in any patient. Of the children with fever, 72% (n = 66) had SIRS. Of the SIRS patients,
8% (n = 5) developed sepsis, 5% (n = 3) severe sepsis and 2% (n = 1) septic shock. Seventy-six
percent (n = 50) of the SIRS patients had fever in combination with respiratory rate >2 SD above
normal for age; 50% (n = 33) had fever with abnormal leukocyte count; 15% (n = 10) had fever with
tachycardia >2 SD above normal for age. Most of the SIRS patients (39%, n = 25) were aged 2–5
years. Twenty-one percent (n = 14) of the children with SIRS and 50% (n = 2) of those with severe
sepsis and septic shock had an underlying disease. In no case was SIRS and sepsis recognized by
doctors and the diagnoses were not recorded on the patients' cards.
Conclusion: Our results would indicate a high risk for sepsis development in children with SIRS.
Early SIRS diagnosis and awareness of risk of developing sepsis could change the medical approach
to the patient in everyday clinical practice, eventually leading to early, goal-directed therapy for
sepsis.
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Background
Sepsis has been recognized as a significant health problem
among children and still remains one of the leading
causes of morbidity and mortality in the child population
[1-3]. In a population-based study in the United States,
>42,000 cases of severe sepsis were reported in children
per annum, with mortality 10.3% or > 4300 nationally
[4]. Unfortunately, no data have been published about
the frequency of sepsis in children in Latvia.
The International consensus conference on pediatric sepsis
and organ dysfunction was held in February 2002 in San
Antonio, where the criteria for adult systemic inflammatory
responses syndrome (SIRS) were modified for pediatric use
and definitions of sepsis, severe sepsis and septic shock for
the pediatric population were revised [5]. Age-specific
norms of vital signs and laboratory data were incorporated
into the definitions of SIRS and sepsis in children [5,6].
Specific norms of vital signs and laboratory data were set
for six clinically and physiologically meaningful age groups
[5,6]. The major novelties in the definition of SIRS for chil-
dren were a mandatory requirement for abnormality of
temperature or leukocyte count for a diagnosis of SIRS in a
pediatric patient [5]. The Institute for Healthcare Improve-
ment (Cambridge, Massachusetts) has identified sepsis as
an area of investigation. One deficiency that leads to subop-
timal care of patients with severe sepsis is inconsistency in
the early diagnosis of severe sepsis and septic shock [7,8].
In everyday clinical practice, one of the major challenges
is still to recognize sepsis when it starts. In its early stages,
sepsis is often mistaken for a milder infection or a condi-
tion resulting from some other therapeutic or surgical
cause. Clinical practice worldwide, and also in Latvia,
demonstrates that some pediatricians associate the term
sepsis with septic shock: only when the blood pressure
drops, the patient no longer responds to intravenous flu-
ids, or respiratory failure develops requiring mechanical
ventilator support, do pediatricians agree that the patient
has septic shock; other doctors agree that the patient is
septic if a positive blood culture is confirmed [9]. Errone-
ously, a patient is not considered to be septic on the basis
of pneumonia, high fever and elevated blood count or
tachycardia.
Rapid recognition and diagnosis of sepsis is critical, and
early goal-directed therapy can be very effective [8,10,11].
Relatively simple strategies have been used in the develop-
ing world to identify sepsis, and well-timed appropriate
treatments, which include empirical antibiotics used in
newborns and infants [12,13] and early aggressive fluid
resuscitation [14], have met with considerable success.
In view of the current definition of sepsis in children and
infants where SIRS plus infection equals sepsis, it is cru-
cially important to recognize systemic inflammatory
response syndrome (SIRS) patients in everyday practice
and to appreciate the importance of multifactorial man-
agement of the potential sepsis sufferer.
The aim of this study was to assess the prevalence of SIRS
and sepsis among hospitalized children in different age
groups with abnormal temperatures in the Children's
Clinical University Hospital.
Methods
Study population and inclusion criteria
This descriptive prospective point prevalence study was
performed in The Children's Clinical University Hospital
in Latvia, which is a tertiary level hospital. Two time peri-
ods, each 24 h, were randomly chosen in January and Feb-
ruary 2007. All patients (n = 943) treated in the hospital
during these two time periods (n = 456 and n = 487
respectively) were screened, and all children with abnor-
mal temperatures (n = 92) were included in the study (Fig-
ure 1). Children with elevated or decreased leukocyte
count for age were also included in the study irrespective
of their temperature. For all children with abnormal tem-
peratures or leukocyte counts, a questionnaire was com-
pleted recording heart rate, respiratory rate, core
temperature and leukocyte count.
The patients were divided into six age groups as proposed
by the International consensus conference on pediatric
sepsis: newborn, neonate, infant, toddler and preschool,
school age, adolescent and young adult [5]. We evaluated
the age-specific vital signs and laboratory variables for
each child. SIRS was confirmed in accordance with the
definition of systemic inflammatory response syndrome
[5]: at least two of the following four criteria must be met,
one of which must be abnormal temperature or leukocyte
count:-
• Core temperature >38.5 or < 36.0°C.
￿ Tachycardia, defined as a mean heart rate >2 SD above
normal for age; or for children <1 yr old, bradycardia,
defined as a mean heart rate <10th percentile for age.
￿ Mean respiratory rate >2 SD above normal for age.
￿ Leukocyte count elevated or depressed for age or >10%
immature neutrophils.
The prevalence of SIRS among hospitalized children was
detected with 95% confidence intervals. The prevalence of
sepsis among children with SIRS was also determined.
We assessed the patients according to age-specific vital
signs and laboratory values to determine the criteria for
diagnosis of SIRS and to gain clinical and demographical
data about SIRS and sepsis patients.BMC Pediatrics 2009, 9:25 http://www.biomedcentral.com/1471-2431/9/25
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The participation of patients was voluntary. Before the
study, each child's parents signed a consent form
approved by the Central Medical Ethics Committee.
During the study period we followed the subject's disease
process, analyzed the outcome of the disease and studied
the final diagnosis, but we did not interfere in the treat-
ment.
Data analysis
The study data were processed using EPI INFO 2000 and
SPSS. For the analysis of patients' data, descriptive statis-
tics were used. For the analysis of patient, data descriptive
statistics were used. For continuous variables, normality
was checked. An appropriate non – parametric test was
chosen, since the data were not distributed normally.
Comparisons of continuous variables between groups
were applied using the Mann – Whitney and Wilcoxon
tests. Results were presented as numbers (n), percent (%),
means and minimum – maximum (min-max). A p value
< 0.05 was considered statistically significant.
Results
SIRS and sepsis prevalence
A total of 943 patients were treated in the hospital, 456 in
the first time period and 487 in the second. Abnormal
temperature was prevalent in 92 patients (10%). All these
children had fevers. No patient had hypothermia. Sev-
enty-two percent (n = 66) of the children with fever had
SIRS, 8% (n = 5) of the SIRS patients in our study devel-
oped sepsis, 5% (n = 3) severe sepsis and 2% (n = 1) septic
shock. The prevalence of SIRS among all the hospitalized
children was 0.07 ± 0.016, but among the children with
fever it was 0.72 ± 0.092.
Confirmation of SIRS diagnosis
A diagnosis of SIRS, in accordance with the definition of
systemic inflammatory response syndrome in children,
was mostly confirmed by the combination of fever with
respiratory rate >2 SD above normal for age (76%, n =
50). Fever with abnormal leukocyte count was present in
50% (n = 33), and fever with tachycardia >2 SD above
normal for age in 15% (n = 10). When children with leu-
kocyte counts elevated or depressed for age but without
temperature abnormalities were also included, only one
additional child met the SIRS criteria.
Age groups, wards where children were treated and 
underlying diseases (premorbid conditions)
Thirty-nine percent (n = 25) of the SIRS patients were in
the 2–5 year age group, 25% (n = 17) in the 1 month-1
year group, 21% (n = 14) in the 13 to <18 year group and
15% (n = 10) in the 6–12 year group. In neither time
period did we identify any patients in the newborn and
Study design Figure 1
Study design.
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neonate age groups. Fifty-six percent (n = 37) of the SIRS
patients were treated in infectious diseases departments,
24% (n = 16) in general pediatrics, 12% (n = 8) in surgical
and 8% (n = 5) in ICU. Twenty-one percent (n = 14) of the
children with SIRS and 50% (n = 2) of children with
severe sepsis and septic shock had an underlying disease.
Sepsis diagnosis
Sepsis, according to definition of the International con-
sensus conference on pediatrics, was confirmed in 60% of
cases by the combination of SIRS with suspected infection
and in 40% of cases by the combination of SIRS with
proven infection. Only 40% of the sepsis patients were
treated in the ICU.
Clinical and demographical data of SIRS and sepsis patients
No gender difference was detected among the SIRS
patients (boy/girl ratio 36/30 in the SIRS group). Median
length of hospitalization was 7 days for SIRS patients
(mean 11.3 days, range 2–62 days) and 9 days (mean16.2
days, range 4–44 days) for sepsis patients. Antibacterial
therapy was used for 33% of SIRS patients (n = 22) and
100% of sepsis patients. In median antibacterial therapy
was started on the 1st day of hospitalization (on average
2nd, earliest on the 1st day, latest on the 13th day) in SIRS
patients and on the 1st day for all sepsis patients. The
median duration of antibacterial therapy was 5 days in
SIRS patients (mean 5.6 days, minimum 0 days, maxi-
mum 15 days) and 8 days in sepsis patients (mean 8.8
days, minimum 4 days, maximum 15 days) (Table 1).
Fatal cases were not established in this study. None of the
SIRS and sepsis cases were recognized by doctors and
recorded on the patients' cards.
Discussion
Several studies on adults and children have established
the prevalence of systemic inflammatory response syn-
drome (SIRS) and sepsis. We used the National Library of
Medicine (National Institutes of Health) database for a lit-
erature search and found a relatively low number of pub-
lications on this subject. We could find no publications
describing the prevalence of SIRS among patients with
abnormal temperatures in children population.
In our study, the prevalence of SIRS among hospitalized
children with fever was 72%. Our literature review
revealed one study reporting a 68% prevalence of SIRS in
pediatric intensive care units [15]; in the adult popula-
tion, 68% of patients admitted to three intensive care
units and three general wards met at least two criteria for
SIRS [16]. In Japan, the prevalence of SIRS reached 84%
among all adult ICU patients [17]. SIRS affected one third
of all hospitalized patients in the study by Brun-Buisson
[18]; it developed in 59% of critically ill obstetric patients
[19] and 82% of admissions to a university hospital in
Canada [20]. Among hospitalized adult medical patients
with new onset of fever in the department of internal
medicine, 95% had SIRS [21]. These data are not fully
comparable with our data because different patient popu-
lations were studied.
Eight percent of the SIRS patients in our study developed
sepsis, 5% severe sepsis and 2% septic shock. Our data are
consistent with other publications showing that severe
sepsis and septic shock occurred in 2–3% of ward patients
[18], and 8% of patients with SIRS progressed to severe
sepsis [17]. However, some studies have reported higher
rates of sepsis: among adult patients with SIRS at three
intensive care units and three general wards, 26% devel-
oped sepsis, 18% severe sepsis and 4% septic shock [16].
In another study on children, 23% of intensive care unit
patients had sepsis, 4% had severe sepsis and 2% had sep-
tic shock [20]. The variances between the rates of sepsis
occurrence could be explained by the different patient
populations in the references. Our data are comparable to
the studies that looked at general hospital wards but they
differ from studies that looked at the intensive care patient
population. We can note that rates for sepsis development
are higher among intensive care unit patients.
The diagnosis of SIRS in our study was based on a combi-
nation of abnormal temperature with respiratory rate >2
SD above normal for age in 76% of cases, a combination
of abnormal temperature with abnormal leukocyte count
in 50%, and abnormal temperature with tachycardia >2
SD above normal for age in 15%. Carvalho et al. [15] in a
study conducted in a pediatric intensive care unit found
Table 1: Clinical and demographical data of SIRS and sepsis patients.
SIRS
(n = 66)
Sepsis, severe sepsis, and septic shock
(n = 9)
P value
Gender boys/girls (number) 36/30 5/4
Duration of hospitalization/days (median, minimum – maximum) 7 (2–62) 16.2 (4–44) NS
Antibacterial therapy 33% (n = 22) 100% (n = 9)
Day of initialization of antibacterial therapy (median, minimum – maximum) 1(1–13) 1 (1-1) NS
Duration of antibacterial therapy/days (median, minimum – maximum) 5 (0–15) 8.8 (4–15) < 0.05
SIRS, systemic inflammatory response syndrome. NS, not significant.BMC Pediatrics 2009, 9:25 http://www.biomedcentral.com/1471-2431/9/25
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that increased heart rate >2 SD above normal value for age
occurred in 85% of SIRS patients, abnormal leukocyte
count in 77%, and increased respiratory frequency >2 SD
above normal value of age in 47.5%.
We found that most (39%) of the SIRS patients were in
the 2–5 year age group with a median age of 30 months,
which is close to the median age of SIRS patients (24
months) found in another study [15]. In the United States
in 1995, the incidence of severe sepsis was highest in
infants [4]; in our study, the infant group was second in
order of frequency of SIRS [4]. Twenty-one percent of chil-
dren with SIRS in our study had an underlying disease; in
contrast, Carvalho et al. [15] noted that 64% of children
with SIRS had no comorbidity. In our study, 50% of the
patients who developed severe sepsis or septic shock had
an underlying disease. Watson et al. [4] in the United
States studied children with severe sepsis using 1995 hos-
pital discharge documentation and found that half the
cases (49%) had underlying disease. This is generally con-
sistent with the conclusions from a study conducted on an
adult population [18], where the major determinant of
prognosis of septic syndromes was related to underlying
diseases.
We found no gender difference among SIRS patients, in
agreement with Carvalho et al., but in another study the
incidence of severe sepsis was 15% higher in boys than in
girls [4].
Including a time period longer than 48 hours and prefer-
ably in different seasons should be necessary to elucidate
the impact of seasonal infections on SIRS and sepsis fre-
quency in hospitalized children.
We would like to point out that laboratory tests are as
important as physiological parameters for the early diag-
nosis of sepsis. During the last decade different biochem-
ical markers of sepsis – C reactive protein (CRP),
procalcitonin (PCT), inflammatory cytokines and acute
phase reactants have been successfully studied and used in
clinical practice in determining the onset of sepsis and
quantifying the response to therapy.
Conclusion
There was a high prevalence of SIRS (72%) among hospi-
talized children with abnormal temperature in The Chil-
dren's Clinical University Hospital in Latvia, the risk of
developing sepsis was considerable: 8% of SIRS patients
developed sepsis, 5% severe sepsis and 2% septic shock.
Isolated abnormal leukocyte count without temperature
abnormality did not meet the criteria for prompt diagno-
sis of SIRS. Timely recognition and understanding of the
role of SIRS in the development of sepsis will contribute
to early diagnosis of sepsis in everyday practice. The spe-
cially modified SIRS criteria for children and revised defi-
nitions of severe sepsis and septic shock for the pediatric
population will improve stepwise and more targeted diag-
nosis of sepsis. Once SIRS is identified, it is crucially
important to keep the patient under observation so that
rapid and appropriate treatment can be initiated.
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